radical surgery is the preferable treatment option for t1-2/n0 low rectal cancer
DESCRIPTION
Radical surgery is the preferable treatment option for T1-2/N0 low rectal cancer. Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering Cancer Center. Great Debates & Updates in GI Malignancies March 28-29, 2014. Rectal Cancer Surgical Options. Local Recurrence - PowerPoint PPT PresentationTRANSCRIPT
Radical surgery is the preferable treatment option for
T1-2/N0 low rectal cancer
Jose G. Guillem, MD, MPH
Department of Surgery
Memorial Sloan Kettering Cancer Center
Great Debates & Updates in GI Malignancies
March 28-29, 2014
Rectal Cancer Surgical Options
Local Recurrence
T1N0 18% 0%
T2N0 47% 6%
Mellgren et al. Dis Colon Rectum, 2000
Inadequacy of baseline ERUS staging of primary and LN disease
Stage Pooled Sensitivity (%)
Pooled Specificity (%)
T1 87.8 98.3
T2 80.5 95.6
T3 96.4 90.6
T4 95.4 98.3
N+ (overall) 73.2 75.8
N+ (2001-2008) 70.9 78.6
Puli SR et al. Ann Surg Oncol.. 2009
*Meta-analysis N = 2732 cases
Evaluated parameters
Sensitivity (%) Specificity (%) Diagnostic Odds Ratio (%)
T stage 87 75 20.4
MRF involvement 77 94 56.1
LN involvement 77 71 8.3
Inadequacy of baseline MRI staging of primary, MRF, and LN involvement
*Meta-analysisN = 1249 cases
Al-Sukhni E et al. Ann Surg Oncol. 2012
6.4mm 5.7mm
ERUS Identification of N1 Disease
Photomicrograph (x20, H&E) of a lymph node that is 70% replaced by tumor.
Micrometastatic Disease
Photomicrograph (x20, H&E) of a lymph node with a 1mm tumor deposit
ERUS Lymph Node Staging is T
Dependent
Stage n pN+ Median
metastasis size (mm)
ERUS Nodal
Accuracy Specificity
pT1 21 6 (29%) 0.3 48 67
pT2 67 20 30%) 4.1 67 75
pT3 44 20 46%) 5.9 84 83
pT4 2 1 (50%) 3.0 100 100
All 134 7 (35%) 4.9 70 76
Landman, et al Dis Col Rectum (2007)
TAE for T1 Rectal Cancer
1. High risk of ca recurrence vs. RAD.
2. TAE has a lower cancer cure rate.
3. Neither adjuvant therapy nor surgical salvage are reliable.
Paty P et al Ann Surg 2002
Bentran D et al Ann Surg , 2005
Nash, G DCR, 2008
Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a surveillance, epidemiology, and
end results (SEER) population-based study
• N = 13,262 pts with rectal cancer• Surgery
– 3715 (28%) local excision – 9547 (72%) major resection
• Preoperative clinical T staging– 953 (7%) Tis– 6223 (47%) T1– 6086 (46%) T2
Bhangu A et al. Annals of Surg. 2013.
Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a surveillance, epidemiology, and
end results (SEER) population-based study
Bhangu A et al. Annals of Surg. 2013.
LE Major resection
Adjusted HR p value
TisOS
CSS76.%95.1%
79%96.2%
1.050.78
0.7770.494
T1OS
CSS71.8%92.3%
80.6%94.4%
1.291.16
<0.0010.236
T2OS
CSS63.1%85.2%
75.6%91.5%
1.381.71
<0.001<0.001
*Estimated 5y OS and CSS
Local excision in early rectal cancer – outcome worse than expected: a population based study
• N = 3694 consecutive stage I rectal ca pts from Swedish Rectal Cancer Register
• 448 LE vs 3246 radical resection (Hartmann, LAR, APR)
• LE pts – LR 11.2% (vs ~3% for all radical procedures
combined)– Relative survival 0.81 (95% CI 0.75-0.88)
Saraste D et al. Eur J Surg Oncol. 2013.
Multimodality salvage of recurrent disease after local excision for rectal cancer
You YN et al. Dis Colon Rectum. 2012.
5y OS s/p salvage 63%
3y RFS s/p salvage 43%
In salvage surgery R0 resection in 80%, Multivisceral 30%, neoadjuvant 70%
Sphincter preservation in 33%
Salvage resection after local excision for rectal cancer
Study, year Initial surgery
Initial stage Salvage surgery of curative intent, n
Rate of R0 resection, %
Rate of sphincter preservation, %
Long-term (5-y) outcome, %
MD Anderson, 2002
LE T1, T2 29 79 34 DFS 59
MSKCC, 2005
LE T1, T2 50 97 30 DFS 53
The Netherlands, 2010
TEMS protocol
T1 16 94 56 DSS (3-y) 58
Rome, 2012 TEMS protocol
T1, T2, T3 26 88.5 43 OS 62
MD Anderson 2012
LE T1, T2, T3 40 80 32 OS 68; RFS (3-y) 43
Predicting lymph node metastases in early rectal cancer
• N = 677 pts with pT1-2 rectal Ca in the Swedish Rectal Cancer Register
Saraste D et al. Eur J Cancer. 2013.
Multivariate analysis OR
95% CI(Ref 1)
T2 1.97 (1.19-3.25)
Poor differentiation 6.47 (2.71-15.4)
Vascular infiltration 4.34 (2.46-7.65)
Predicting lymph node metastases in early rectal cancer
Saraste D et al. Eur J Cancer. 2013.
Preoperative Considerations if Pursuing a Sphincter Preserving Resection
• Determination is both preop and intraop
• Body habitus, sphincter mass?
• Sphincter tone, squeeze?
• Co-morbidities?
• Patient expectations, enthusiasm?
• Understands the “good news/bad news” post operative scenario.
As in fly fishing…“Match the Hatch”
“Match the Disease”
Should be the governing paradigm in the management of rectal cancer
J Guillem, Ann Surg 2007